Susan Shiff
Directeur/Bestuurslid bij CARA THERAPEUTICS, INC.
Vermogen: 10 833 $ op 30-04-2024
Actieve functies van Susan Shiff
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARA THERAPEUTICS, INC. | Directeur/Bestuurslid | 26-06-2020 | - |
Independent Dir/Board Member | 26-06-2020 | - | |
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Directeur/Bestuurslid | 05-06-2018 | - |
Merck Global Health Innovation Fund LLC
Merck Global Health Innovation Fund LLC Investment ManagersFinance Merck Global Health Innovation Fund LLC invests in companies located across the globe with focus on North America and Europe. The fund focuses on companies operating in the fields of healthcare services. It provides financing for early stage and growth stage capital requirements with an investment size of USD 5 - 10 million. | Directeur/Bestuurslid | - | - |
New Jersey Symphony Orchestra | Directeur/Bestuurslid | - | - |
Loopbaan van Susan Shiff
Eerdere bekende functies van Susan Shiff
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Ontada | President | 01-03-2021 | 01-07-2023 |
MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2014 | 01-03-2021 |
Teva Pharmaceutics | Corporate Officer/Principal | - | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Opleiding van Susan Shiff
University of California, Los Angeles | Doctorate Degree |
Cornell University | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 9 |
2 | |
Verenigd Koninkrijk | 2 |
Operationeel
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
PFIZER, INC. | Health Technology |
CARA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
New Jersey Symphony Orchestra | |
Teva Pharmaceutics | |
Merck Global Health Innovation Fund LLC
Merck Global Health Innovation Fund LLC Investment ManagersFinance Merck Global Health Innovation Fund LLC invests in companies located across the globe with focus on North America and Europe. The fund focuses on companies operating in the fields of healthcare services. It provides financing for early stage and growth stage capital requirements with an investment size of USD 5 - 10 million. | Finance |
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Technology Services |
Ontada |
- Beurs
- Insiders
- Susan Shiff
- Ervaring